Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 409


Tossing and Turning in Bed: Nocturnal Movements in Parkinson's Disease.

Mirelman A, Hillel I, Rochester L, Del Din S, Bloem BR, Avanzino L, Nieuwboer A, Maidan I, Herman T, Thaler A, Gurevich T, Kestenbaum M, Orr-Urtreger A, Brys M, Cedarbaum JM, Giladi N, Hausdorff JM.

Mov Disord. 2020 Feb 20. doi: 10.1002/mds.28006. [Epub ahead of print]


Erdheim-Chester disease presenting with chorea and mimicking IgG4-related disorder.

Miron G, Karni A, Faust-Soher A, Giladi N, Alroy H, Gadoth A.

Neurol Clin Pract. 2019 Dec;9(6):524-526. doi: 10.1212/CPJ.0000000000000617. No abstract available.


Repeated Intravenous Amantadine Infusions in Advanced Parkinsonism: Experience of a Large Movement Disorder Center.

Kestenbaum M, Abu Snineh M, Nussbaum T, Gadoth A, Rosenberg A, Hindi A, Zitser J, Thaler A, Giladi N, Gurevich T.

Isr Med Assoc J. 2019 Dec;12(21):812-816.


What happens before the first step? A New Approach to Quantifying Gait Initiation Using a Wearable Sensor.

Gazit E, Buchman AS, Dawe R, Curran TA, Mirelman A, Giladi N, Hausdorff JM.

Gait Posture. 2020 Feb;76:128-135. doi: 10.1016/j.gaitpost.2019.11.007. Epub 2019 Nov 9.


Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?

Goldstein O, Gana-Weisz M, Cohen-Avinoam D, Shiner T, Thaler A, Cedarbaum JM, John S, Lalioti M, Gurevich T, Bar-Shira A, Mirelman A, Giladi N, Orr-Urtreger A.

Mol Genet Metab. 2019 Dec;128(4):470-475. doi: 10.1016/j.ymgme.2019.10.001. Epub 2019 Oct 13.


Successful Negotiation of Anticipated and Unanticipated Obstacles in Young and Older Adults: Not All Is as Expected.

Eyal S, Kurz I, Mirelman A, Maidan I, Giladi N, Hausdorff JM.

Gerontology. 2020;66(2):187-196. doi: 10.1159/000502140. Epub 2019 Aug 28.


A new approach to quantifying the EEG during walking: Initial evidence of gait related potentials and their changes with aging and dual tasking.

Maidan I, Patashov D, Shustak S, Fahoum F, Gazit E, Shapiro B, Levy A, Sosnik R, Giladi N, Hausdorff JM, Mirelman A.

Exp Gerontol. 2019 Oct 15;126:110709. doi: 10.1016/j.exger.2019.110709. Epub 2019 Aug 23.


Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.

Agalliu I, Ortega RA, Luciano MS, Mirelman A, Pont-Sunyer C, Brockmann K, Vilas D, Tolosa E, Berg D, Warø B, Glickman A, Raymond D, Inzelberg R, Ruiz-Martinez J, Mondragon E, Friedman E, Hassin-Baer S, Alcalay RN, Mejia-Santana H, Aasly J, Foroud T, Marder K, Giladi N, Bressman S, Saunders-Pullman R.

Mov Disord. 2019 Sep;34(9):1392-1398. doi: 10.1002/mds.27807. Epub 2019 Jul 26.


The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort Study.

Peretz C, Rozani V, Giladi N, El-Ad B, Tsamir J, Hemo B, Gurevich T.

Neuroepidemiology. 2019;53(1-2):13-19. doi: 10.1159/000492672. Epub 2019 Jun 14.


Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill®) in Parkinson's disease.

LeWitt PA, Giladi N, Navon N.

Parkinsonism Relat Disord. 2019 Aug;65:131-138. doi: 10.1016/j.parkreldis.2019.05.032. Epub 2019 May 22.


Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease.

Kozlovski T, Mitelpunkt A, Thaler A, Gurevich T, Orr-Urtreger A, Gana-Weisz M, Shachar N, Galili T, Marcus-Kalish M, Bressman S, Marder K, Giladi N, Benjamini Y, Mirelman A.

Front Neurol. 2019 May 21;10:531. doi: 10.3389/fneur.2019.00531. eCollection 2019.


Using wearables to assess bradykinesia and rigidity in patients with Parkinson's disease: a focused, narrative review of the literature.

Teshuva I, Hillel I, Gazit E, Giladi N, Mirelman A, Hausdorff JM.

J Neural Transm (Vienna). 2019 Jun;126(6):699-710. doi: 10.1007/s00702-019-02017-9. Epub 2019 May 22. Review.


Is every-day walking in older adults more analogous to dual-task walking or to usual walking? Elucidating the gaps between gait performance in the lab and during 24/7 monitoring.

Hillel I, Gazit E, Nieuwboer A, Avanzino L, Rochester L, Cereatti A, Croce UD, Rikkert MO, Bloem BR, Pelosin E, Del Din S, Ginis P, Giladi N, Mirelman A, Hausdorff JM.

Eur Rev Aging Phys Act. 2019 May 3;16:6. doi: 10.1186/s11556-019-0214-5. eCollection 2019.


Gait impairments in Parkinson's disease.

Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL, Hass CJ, Hausdorff JM, Pelosin E, Almeida QJ.

Lancet Neurol. 2019 Jul;18(7):697-708. doi: 10.1016/S1474-4422(19)30044-4. Epub 2019 Apr 8. Review.


Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort study.

Rozani V, Giladi N, Gurevich T, El-Ad B, Tsamir J, Hemo B, Peretz C.

Parkinsonism Relat Disord. 2019 Jul;64:90-96. doi: 10.1016/j.parkreldis.2019.03.010. Epub 2019 Mar 23.


Altered organization of the dorsal attention network is associated with freezing of gait in Parkinson's disease.

Maidan I, Jacob Y, Giladi N, Hausdorff JM, Mirelman A.

Parkinsonism Relat Disord. 2019 Jun;63:77-82. doi: 10.1016/j.parkreldis.2019.02.036. Epub 2019 Feb 23.


A Case with Beta-Propeller Protein Associated Neurodegeneration with Smooth Response to Levodopa Treatment.

Zitser J, Giladi N, Gurevich T.

Mov Disord Clin Pract. 2018 Mar 23;5(3):327-329. doi: 10.1002/mdc3.12604. eCollection 2018 May-Jun. No abstract available.


Network abnormalities among non-manifesting Parkinson disease related LRRK2 mutation carriers.

Jacob Y, Rosenberg-Katz K, Gurevich T, Helmich RC, Bloem BR, Orr-Urtreger A, Giladi N, Mirelman A, Hendler T, Thaler A.

Hum Brain Mapp. 2019 Jun 1;40(8):2546-2555. doi: 10.1002/hbm.24543. Epub 2019 Feb 21.


Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson's disease.

Galperin I, Hillel I, Del Din S, Bekkers EMJ, Nieuwboer A, Abbruzzese G, Avanzino L, Nieuwhof F, Bloem BR, Rochester L, Della Croce U, Cereatti A, Giladi N, Mirelman A, Hausdorff JM.

Parkinsonism Relat Disord. 2019 May;62:85-90. doi: 10.1016/j.parkreldis.2019.01.022. Epub 2019 Jan 29.


Distinguishing Dementia With Lewy Bodies From Alzheimer Disease: What is the Influence of the GBA Genotype in Ashkenazi Jews?

Bregman N, Kavé G, Mirelman A, Thaler A, Gana Weisz M, Bar-Shira A, Orr-Urtreger A, Giladi N, Shiner T.

Alzheimer Dis Assoc Disord. 2019 Jul-Sep;33(3):279-281. doi: 10.1097/WAD.0000000000000283.


Changes in event-related potentials during dual task walking in aging and Parkinson's disease.

Maidan I, Fahoum F, Shustak S, Gazit E, Patashov D, Tchertov D, Giladi N, Hausdorff JM, Mirelman A.

Clin Neurophysiol. 2019 Feb;130(2):224-230. doi: 10.1016/j.clinph.2018.11.019. Epub 2018 Dec 8.


Gait festination in parkinsonism: introduction of two phenotypes.

Nonnekes J, Giladi N, Guha A, Fietzek UM, Bloem BR, Růžička E.

J Neurol. 2019 Feb;266(2):426-430. doi: 10.1007/s00415-018-9146-7. Epub 2018 Dec 7. Review.


Evidence for increased completed suicide in first-degree relatives of LRRK2 G2019S mutation Parkinson's disease.

Ortega RA, Groves M, Mirelman A, Alcalay RN, Raymond D, Elango S, Mejia-Santana H, Giladi N, Marder K, Bressman SB, Saunders-Pullman R.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):843-844. doi: 10.1136/jnnp-2018-319364. Epub 2018 Nov 8. No abstract available.


The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of events.

Weiss A, Herman T, Mirelman A, Shiratzky SS, Giladi N, Barnes LL, Bennett DA, Buchman AS, Hausdorff JM.

Gait Posture. 2019 Jan;67:224-229. doi: 10.1016/j.gaitpost.2018.10.018. Epub 2018 Oct 21.


Single center experience with medical cannabis in Gilles de la Tourette syndrome.

Thaler A, Arad S, Schleider LB, Knaani J, Taichman T, Giladi N, Gurevich T.

Parkinsonism Relat Disord. 2019 Apr;61:211-213. doi: 10.1016/j.parkreldis.2018.10.004. Epub 2018 Oct 1.


Survival rates among Parkinson's disease patients who carry mutations in the LRRK2 and GBA genes.

Thaler A, Kozlovski T, Gurevich T, Bar-Shira A, Gana-Weisz M, Orr-Urtreger A, Giladi N, Mirelman A.

Mov Disord. 2018 Oct;33(10):1656-1660. doi: 10.1002/mds.27490. Epub 2018 Oct 4.


Depressive symptoms may increase the risk of the future development of freezing of gait in patients with Parkinson's disease: Findings from a 5-year prospective study.

Herman T, Shema-Shiratzky S, Arie L, Giladi N, Hausdorff JM.

Parkinsonism Relat Disord. 2019 Mar;60:98-104. doi: 10.1016/j.parkreldis.2018.09.013. Epub 2018 Sep 11.


Dysphagia characteristics in Huntington's disease patients: insights from the Fiberoptic Endoscopic Evaluation of Swallowing and the Swallowing Disturbances Questionnaire.

Manor Y, Oestreicher-Kedem Y, Gad A, Zitser J, Faust-Socher A, Shpunt D, Naor S, Inbar N, Kestenbaum M, Giladi N, Gurevich T.

CNS Spectr. 2019 Aug;24(4):413-418. doi: 10.1017/S1092852918001037. Epub 2018 Sep 10.


FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease.

Matthews DC, Lerman H, Lukic A, Andrews RD, Mirelman A, Wernick MN, Giladi N, Strother SC, Evans KC, Cedarbaum JM, Even-Sapir E.

Neuroimage Clin. 2018 Aug 10;20:572-579. doi: 10.1016/j.nicl.2018.08.006. eCollection 2018.


Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study.

Rozani V, Gurevich T, Giladi N, El-Ad B, Tsamir J, Hemo B, Peretz C.

Mov Disord. 2018 Aug;33(8):1298-1305. doi: 10.1002/mds.27413. Epub 2018 Aug 25.


Increased substantia nigra echogenicity in LRRK2 family members without mutations.

Pullman M, Ortega R, Glickman A, Deik A, Raymond D, Marder K, Giladi N, Bressman S, Hagenah J, Brüggemann N, Saunders-Pullman R.

Mov Disord. 2018 Sep;33(9):1504-1505. doi: 10.1002/mds.27443. Epub 2018 Aug 25. No abstract available.


What predicts falls in Parkinson disease?: Observations from the Parkinson's Foundation registry.

Parashos SA, Bloem BR, Browner NM, Giladi N, Gurevich T, Hausdorff JM, He Y, Lyons KE, Mari Z, Morgan JC, Post B, Schmidt PN, Wielinski CL.

Neurol Clin Pract. 2018 Jun;8(3):214-222. doi: 10.1212/CPJ.0000000000000461. Erratum in: Neurol Clin Pract. 2018 Aug;8(4):278.


Altered reward-related neural responses in non-manifesting carriers of the Parkinson disease related LRRK2 mutation.

Thaler A, Gonen T, Mirelman A, Helmich RC, Gurevich T, Orr-Urtreger A, Bloem BR, Giladi N, Hendler T; LRRK2 Ashkenazi Jewish consortium.

Brain Imaging Behav. 2019 Aug;13(4):1009-1020. doi: 10.1007/s11682-018-9920-2.


Pace of movement: the role of single neurons in the subthalamic nucleus.

Tankus A, Mirelman A, Giladi N, Fried I, Hausdorff JM.

J Neurosurg. 2018 Jun 1:1-6. doi: 10.3171/2018.1.JNS171859. [Epub ahead of print]


SPARC: a new approach to quantifying gait smoothness in patients with Parkinson's disease.

Beck Y, Herman T, Brozgol M, Giladi N, Mirelman A, Hausdorff JM.

J Neuroeng Rehabil. 2018 Jun 18;15(1):49. doi: 10.1186/s12984-018-0398-3.


Consensus for the measurement of the camptocormia angle in the standing patient.

Margraf NG, Wolke R, Granert O, Berardelli A, Bloem BR, Djaldetti R, Espay AJ, Fasano A, Furusawa Y, Giladi N, Hallett M, Jankovic J, Murata M, Tinazzi M, Volkmann J, Berg D, Deuschl G.

Parkinsonism Relat Disord. 2018 Jul;52:1-5. doi: 10.1016/j.parkreldis.2018.06.013. Epub 2018 Jun 8.


Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected Relatives.

Thaler A, Kliper E, Maidan I, Herman T, Rosenberg-Katz K, Bregman N, Gurevich T, Shiner T, Hausdorff JM, Orr-Urtreger A, Giladi N, Mirelman A.

Brain Topogr. 2018 Nov;31(6):1029-1036. doi: 10.1007/s10548-018-0653-8. Epub 2018 May 30.


Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.

Thaler A, Bregman N, Gurevich T, Shiner T, Dror Y, Zmira O, Gan-Or Z, Bar-Shira A, Gana-Weisz M, Orr-Urtreger A, Giladi N, Mirelman A.

Parkinsonism Relat Disord. 2018 Oct;55:45-49. doi: 10.1016/j.parkreldis.2018.05.009. Epub 2018 May 17.


Model-based and Model-free Machine Learning Techniques for Diagnostic Prediction and Classification of Clinical Outcomes in Parkinson's Disease.

Gao C, Sun H, Wang T, Tang M, Bohnen NI, Müller MLTM, Herman T, Giladi N, Kalinin A, Spino C, Dauer W, Hausdorff JM, Dinov ID.

Sci Rep. 2018 May 8;8(1):7129. doi: 10.1038/s41598-018-24783-4.


Basal ganglia and beyond: The interplay between motor and cognitive aspects in Parkinson's disease rehabilitation.

Ferrazzoli D, Ortelli P, Madeo G, Giladi N, Petzinger GM, Frazzitta G.

Neurosci Biobehav Rev. 2018 Jul;90:294-308. doi: 10.1016/j.neubiorev.2018.05.007. Epub 2018 May 4. Review.


Treadmill walking reduces pre-frontal activation in patients with Parkinson's disease.

Thumm PC, Maidan I, Brozgol M, Shustak S, Gazit E, Shema Shiratzki S, Bernad-Elazari H, Beck Y, Giladi N, Hausdorff JM, Mirelman A.

Gait Posture. 2018 May;62:384-387. doi: 10.1016/j.gaitpost.2018.03.041. Epub 2018 Mar 28.


Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.

Mirelman A, Saunders-Pullman R, Alcalay RN, Shustak S, Thaler A, Gurevich T, Raymond D, Mejia-Santana H, Orbe Reilly M, Ozelius L, Clark L, Gana-Weisz M, Bar-Shira A, Orr-Utreger A, Bressman SB, Marder K, Giladi N; AJ LRRK2 Consortium.

Mov Disord. 2018 Jul;33(6):966-973. doi: 10.1002/mds.27342. Epub 2018 Mar 30.


Evidence for Differential Effects of 2 Forms of Exercise on Prefrontal Plasticity During Walking in Parkinson's Disease.

Maidan I, Nieuwhof F, Bernad-Elazari H, Bloem BR, Giladi N, Hausdorff JM, Claassen JAHR, Mirelman A.

Neurorehabil Neural Repair. 2018 Mar;32(3):200-208. doi: 10.1177/1545968318763750. Epub 2018 Mar 16.


How attention modulates encoding of dynamic stimuli in older adults.

Oren N, Shapira-Lichter I, Lerner Y, Hendler T, Giladi N, Ash EL.

Behav Brain Res. 2018 Jul 16;347:209-218. doi: 10.1016/j.bbr.2018.02.031. Epub 2018 Feb 25.


Effectiveness of a Goal-Based Intensive Rehabilitation in Parkinsonian Patients in Advanced Stages of Disease.

Ortelli P, Ferrazzoli D, Bera R, Caremani L, Giladi N, Maestri R, Frazzitta G.

J Parkinsons Dis. 2018;8(1):113-119. doi: 10.3233/JPD-171247.


Prefrontal cortex activation during obstacle negotiation: What's the effect size and timing?

Maidan I, Shustak S, Sharon T, Bernad-Elazari H, Geffen N, Giladi N, Hausdorff JM, Mirelman A.

Brain Cogn. 2018 Apr;122:45-51. doi: 10.1016/j.bandc.2018.02.006. Epub 2018 Feb 15.


Who will remain tremor dominant? The possible role of cognitive reserve in the time course of two common Parkinson's disease motor subtypes.

Herman T, Shema-Shiratzky S, Arie L, Giladi N, Hausdorff JM.

J Neural Transm (Vienna). 2018 Jun;125(6):1007-1011. doi: 10.1007/s00702-018-1859-3. Epub 2018 Feb 15.


Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease.

Dagan M, Herman T, Harrison R, Zhou J, Giladi N, Ruffini G, Manor B, Hausdorff JM.

Mov Disord. 2018 Apr;33(4):642-646. doi: 10.1002/mds.27300. Epub 2018 Feb 13.


Progression in the LRRK2-Asssociated Parkinson Disease Population.

Saunders-Pullman R, Mirelman A, Alcalay RN, Wang C, Ortega RA, Raymond D, Mejia-Santana H, Orbe-Reilly M, Johannes BA, Thaler A, Ozelius L, Orr-Urtreger A, Marder KS, Giladi N, Bressman SB; LRRK2 Ashkenazi Jewish Consortium.

JAMA Neurol. 2018 Mar 1;75(3):312-319. doi: 10.1001/jamaneurol.2017.4019. Erratum in: JAMA Neurol. 2018 Jun 1;75(6):763.


Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease.

San Luciano M, Wang C, Ortega RA, Giladi N, Marder K, Bressman S, Saunders-Pullman R; Michael J Fox Foundation LRRK2 Consortium.

Ann Clin Transl Neurol. 2017 Oct 19;4(11):801-810. doi: 10.1002/acn3.489. eCollection 2017 Nov.

Supplemental Content

Loading ...
Support Center